Evercore ISI Maintains a Hold Rating on Intuitive Surgical (ISRG)

According to TipRanks.com, Kumar is a 3-star analyst with an average return of 2.3% and a 53.9% success rate. Kumar covers the Healthcare sector, focusing on stocks such as Bausch + Lomb Corporation, Zimmer Biomet Holdings, and Edwards Lifesciences.

Intuitive Surgical has an analyst consensus of Moderate Buy, with a price target consensus of $248.21, implying a 19.7% upside from current levels. In a report issued on July 15, Morgan Stanley also maintained a Hold rating on the stock with a $225.00 price target.

See the top stocks recommended by analysts >>

The company has a one-year high of $369.69 and a one-year low of $186.83. Currently, Intuitive Surgical has an average volume of 2.25M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Intuitive Surgical, Inc. manufactures and develops robotic-assisted products, most notably with the da Vinci surgical system and related instruments and accessories, to improve clinical outcomes of patients through minimally invasive surgery. Its products include Da Vinci and Ion. The company was founded in 1995 and is headquartered in Sunnyvale, California.

Read More on ISRG:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More